International Journal of Mevlana Medical Sciences
ISSN: 2147-8236
Original Research/Reviews/Case Reports/Letters/Brief Communications Article
Sample IJMMS Paper
First Author 1, Second Author 1, Third Author 2,*
1
2
*
Full Affiliation/Address
Full Affiliation/Address
Corresponding Author; E-Mail: ; Phone.: ; Fax:
Abstract—A well-prepared abstract enables the reader to identify the basic content of a document
quickly and accurately, to determine its relevance to their interests, and thus to decide whether to
read the document in its entirety. The Abstract should be informative and completely selfexplanatory, provide a clear statement of the problem, the proposed approach or solution, and point
out major findings and conclusions. The Abstract should be 100 to 200 words in length. The
abstract should be written in the past tense. Standard nomenclature should be used and
abbreviations should be avoided. No literature should be cited. The keyword list provides the
opportunity to add keywords, used by the indexing and abstracting services, in addition to those
already present in the title. Judicious use of keywords may increase the ease with which interested
parties can locate our article.
Keywords—First keyword, Second keyword, Third keyword, Fourth keyword
1. INTRODUCTION
This document is a template. An electronic copy can be downloaded from the IJMMS website.
The manuscript is written in Microsoft Word, Time New Roman 12pt, which can be downloaded at
the website: http://www.atscience.org/IJMMS.
A title of article should be the fewest possible words that accurately describe the content of the
paper. Indexing and abstracting services depend on the accuracy of the title, extracting from it
keywords useful in cross-referencing and computer searching. An improperly titled paper may
never reach the audience for which it was intended, so be specific.
The Introduction should provide a clear background, a clear statement of the problem, the
relevant literature on the subject, the proposed approach or solution, and the new value of research
which it is innovation. It should be understandable to colleagues from a broad range of scientific
disciplines. Organization and citation of the bibliography are made in Vancouver style in sign [1],
[2] and so on. The terms in foreign languages are written italic (italic).
The text should be divided into sections, each with a separate IJMMS heading style and
numbered consecutively. Authors are suggested to present their articles in the section structure:
Introduction - Methods – Results – Discussion – Conclusion. For case reports, Introduction – Case
Report – Discussion.
Literature review that has been done author used in the chapter "Introduction" to explain the
difference of the manuscript with other papers, that it is innovative, it are used in the chapter
"Methods" to describe the step of research and used in the chapter "Results and Discussion" to
International Journal of Mevlana Medical Sciences
ISSN: 2147-8236
support the analysis of the results [2]. If the manuscript was written really have high originality,
which proposed a new method, the additional chapter after the "Introduction" chapter and before the
"Methods" chapter can be added to explain briefly the theory and/or the proposed method [4].
1.1. Page Layout
Your paper must use a page size corresponding to A4 which is 210mm (8.27") wide and 297mm
(11.69") long. The margins must be set as follows:
 Top = 25mm
 Bottom = 20mm
 Left = Right = 20mm
Your paper must be in single column format.
1.2. Page Style
All paragraphs must be indented. All paragraphs must be justified, i.e. both left-justified and
right-justified.
1.3. Text Font of Entire Document
The entire document should be in Times New Roman or Times font. Other font types may be
used if needed for special purposes.
1.4. Title and Author Details
The title is concise description of the article, covering main aspects of the work.
Title must be in 24 pt Regular font. Author name must be in 11 pt Regular font. Author
affiliation must be in 10 pt Italic.
All title and author details must be in single-column format and must be centered.
Every word in a title must be capitalized except for short minor words such as “a”, “an”, “and”,
“as”, “at”, “by”, “for”, “from”, “if”, “in”, “into”, “on”, “or”, “of”, “the”, “to”, “with”.
Author details must not show any professional title, any academic title (e.g. MD.) or any
membership of any professional organization.
To avoid confusion, the family name must be written as the last part of each author name (e.g.
John A.K. Smith).
1.5. Page Numbers, Headers and Footers
Page numbers, headers and footers must not be used.
1.6. Links and Bookmarks
All hypertext links and section bookmarks will be removed from papers during the processing of
papers for publication. If you need to refer to an Internet email address or URL in your paper, you
must type out the address or URL fully in Regular font.
1.7. References
The heading of the References section must not be numbered. All reference items must be in 12
pt font. Please use Regular and Italic styles to distinguish different fields as shown in the
References section. Number the reference items consecutively in square brackets (e.g. [1]).
International Journal of Mevlana Medical Sciences
ISSN: 2147-8236
References in the text should be given as numbers within square brackets, placed in line with the
text and in order of appearance (Vancouver style). They should be listed in numerical order at the
end of the paper.
All authors should be included in a reference when there are fewer than 6 but only the first three
followed by et al. when there are 6 or more.
Authors' names should be followed by the title of article, abbreviated name of the Journal (as per
PubMed abbreviations), year, volume and first and last page numbers.
References to books should state the author, followed by chapter title, Editors' names, book title,
place of publication, publisher, year, and appropriate page numbers.
2. RESEARCH METHOD
Explaining research chronological, including research design, research procedure [1]-[3]. The
description of the course of research should be supported references, so the explanation can be
accepted scientifically [2], [4].
Tables and Figures are presented center, as shown below and cited in the manuscript.
Table 1. The diagnosis of ...
Patient
Age( year)
Diagnosis
x
10
Positive
y
15
Negative
z
20
Negative
Figure 1. 51 year-old woman with history of histoplasmosis, presenting with face and upper
extremity swelling
Here is a sample equation, with equation number right justified:
𝐴 = 𝜋𝑟 2
(1)
Numbered equations are referred to subsequently in a consistent way, such as Equation (4) or Eq.
(4). Wherever possible, prepare mathematical characters and equations using Word’s Equation
Editor (available in Microsoft Office 2003 and later).
3. RESULTS AND DISCUSSION
International Journal of Mevlana Medical Sciences
ISSN: 2147-8236
In this section, it is explained the results of research and at the same time is given the
comprehensive discussion. Results can be presented in figures, graphs, tables and others that make
the reader understand easily [2], [5]. The discussion can be made in several sub-chapters.
3.1. Sub section 1
xxx xxx xxx
3.2. Sub section 2
yyy yyy yyy
4. CONCLUSION
Provide a statement that what is expected, as stated in the "Introduction" chapter can ultimately
result in "Results and Discussion" chapter, so there is compatibility. Moreover, it can also be added
the prospect of the development of research results and application prospects of further studies into
the next (based on result and discussion).
DECLARATION OF INTEREST
The authors report no conflicts of interest. The authors alone are responsible for the content and
writing of this article.
ACKNOWLEDGEMENTS
xxx xxx xxx
REFERENCES
[1] Hirayama T, Danks L, Sabokbar A, Athanasou N A. Osteoclast formation and activity in the
pathogenesis of osteoporosis in rheumatoid arthritis. Rheumatology 2002;41:1232-9.
[2] Bastin S, Bird H, Gamble G, Cundy T. Paget's disease of bone—becoming a rarity?
Rheumatology 2009 published on 16 July 2009. doi:10.1093/rheumatology/kep212
[3] Mitchell SC, Waring RH. S-Oxygenase III human harmacogenetics. In: Damani LA, ed.
Sulphur-containing drugs and related organic compounds, Vol. 2B. New York: Ellis Horwood,
1989:101-19.